Account
Inquiry
Tirzepatide pens contain a lyophilized powder formulation of the triple agonist peptide that targets glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). This pharmaceutical grade compound demonstrates high binding affinity with EC50 values of 5.79 nM (GCGR), 0.0643 nM (GIPR), and 0.775 nM (GLP-1R) in human receptors.
The Tirzepatide pens formulation shows significant activity in metabolic regulation studies, particularly in glucose tolerance improvement and weight management research. When activated through the glucagon receptor pathway, it demonstrates notable effects on energy expenditure and body weight reduction.
Our Tirzepatide pens are supplied as sterile lyophilized powder in sealed vials under controlled conditions to ensure stability and purity. The product is intended for research applications only and not for human consumption.
Yikes, the shipping was incredibly fast! I was genuinely surprised when the package arrived ahead of schedule. Everything was packaged securely and discreetly, which is always appreciated. The communication from the seller was prompt and professional, answering my preliminary questions clearly. As for the items themselves, upon visual inspection, they appear to be of high quality and exactly as described. The vials are properly sealed and labeled. While I cannot comment on specific research outcomes, the overall service experience from order to delivery was seamless and efficient. This level of attention to logistics and customer service builds significant confidence. I would certainly consider this supplier for future research needs based on this positive initial interaction.
